The pill formulation of zanubrutinib (Brukinsa; BeOne) is currently authorised for all 5 indications throughout various hematological cancers.As opposed to regular remedies that require elimination from the body, Lenmeldy isn't going to must be taken off. Biodistribution experiments have revealed that Lenmeldy is dispersed to hematopoietic tissues